227 posters,  30 sessions,  7 topics,  1256 authors 

ePostersLive® by SciGen® Technologies S.A. All rights reserved.

HTX-011, a proprietary, extended-release combination of bupivacaine and meloxicam, reduced pain intensity and opioid consumption for 96 hours following abdominoplasty
Sat, April 8, 9:45-9:55 am
Screen C

Please note, medically challenging cases are removed three months after the meeting and scientific abstracts after three years.


Average: 5 (1 vote)


HTX-011, a Proprietary, Extended-Release Combination of Bupivacaine and Meloxicam, Reduced Pain Intensity and Opioid Consumption for 96 Hours Following Abdominoplasty


David Leiman, MD1; Harold S. Minkowitz, MD1; Sanjay S. Patel, PhD2; Guy Boccia, MA2; Alice Chu, MA2; Linda Heiner, RN2; Mary Rose Keller2; Erol Onel, MD2; Tom Ottoboni, PhD2; Barry Quart, PharmD2


HD Research Corp., Houston, TX; Heron Therapeutics, San Diego, CA


Enter Poster ID (e.gGoNextPreviousCurrent